Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Opsens Inc T.OPS

OpSens Inc. is a medical device cardiology-focused company. The Company offers an advanced optical-based pressure guidewire that aims at improving the clinical outcome of patients with coronary artery disease. The Company’s segments include Medical and Industrial. The Medical segment focuses on physiological measurements, such as Fractional Flow Reserve (FFR) and Diastolic Pressure Ratio (dPR... see more

TSX:OPS - Post Discussion

Opsens Inc > OPSENS ANNOUNCES FOURTH QUARTER RESULTS
View:
Post by Betteryear2 on Nov 22, 2023 11:04am

OPSENS ANNOUNCES FOURTH QUARTER RESULTS

Total Revenue up 37% - Medical Sales up 42% - Gross Margin 58%

QUEBEC CITY, QCNov. 22, 2023 /CNW/ - OpSens Inc. ("OpSens" or the "Company") (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused company delivering innovative solutions based on its proprietary optical technology, today reported its results for the fourth quarter of fiscal year 2023, ended August 31, 2023.

OPSENS ANNOUNCES FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIAL RESULTS (newswire.ca)

Comment by Possibleidiot01 on Nov 25, 2023 4:14pm
Results were great ; not happy with the deal . Cash and cash equivalents of $17.5 million at November 30, 2022 ($23.8 million at August 31, 2022). Cash and cash equivalents of $20.5 million at May 31, 2023 ($21.9 million at 28 February, 2023). Cash now at $18.1 million so they could have waited and got more in my opinion. Cash burn $3.8 million since February in the rampup. Liabilities up $2 ...more  
Comment by tannin on Nov 27, 2023 1:22pm
also not happy with the deal.....but think it's done and dusted.......hard to replace in my portfolio......any ideas ? For others, you might look at KSI.
Comment by Possibleidiot01 on Nov 28, 2023 7:11am
tannin I sent this message awhile back to somebody on another board who never bothered to pick it up. Oh well. To update , the picks Vitalhub has been undergoing a re-rating surge which hopefully holds. On my watchlists, Kneat is probably at the top. I would be interested in knowing what you think they might be as opposed to H2O Innovation , if you would like to share . You might want to ...more  
Comment by tannin on Nov 29, 2023 7:21pm
Appreciate your thoughts Possibleidiot..........Will do some work on those names. Currently nervous given my take on where we are in the economic cycle......nervous in the sense of, buying high flyers right now ( high flyers being a very relative term of course...let's just say 'winners'.......but thinking of 6-8 months from now, building a list of ....if the price is right, i want in. ...more  
Comment by GoldenArm1 on Nov 27, 2023 1:30pm
Like I said awhile back when I sold. They are not profitable and I can't see them profitable until much later. You can buy now and wait but I'm waiting for positive news on the profitability side.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities